hip fracture
Conditions
Interventions
Rivaroxaban group:oral Rivaroxaban
low-molecular-weight heparin group:hypodermic injection low-molecular-weight heparin
sequential therapy group:low-molecular-weight heparin with sequential Rivaroxaban
Sponsors
The Second Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: fractures were caused by fall-induced damage, the patients were admitted to the hospital within 24h after injury,the patients were diagnosed by X-ray or CT, and all patients received internal fixation.
Exclusion criteria
Exclusion criteria: lower extremity DVT was confirmed by preoperative imaging, the patients had a history of thromboembolic disease and were undergoing anticoagulant therapy, the patients with hemorrhagic diseases or major bleeding history (such as intracranial hemorrhage or gastrointestinal bleeding that required blood transfusion), the patients who were accompanied by severe liver diseases, the patients with coagulation disorders or contraindications to anticoagulation, and the patients who were contraindicated to Rivaroxabanor low-molecular-weight heparin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of postoperative VTE; | — |
Secondary
| Measure | Time frame |
|---|---|
| compliance;treatment costs;bleeding;wound complications; | — |
Countries
China
Contacts
Public ContactTang Yilun
the Second Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed